Sleep-disordered breathing and fragmented sleep are associated with higher levels of fasting glucose and hemoglobin A1c in black adults.
The FDA has expanded the approval of Inspire therapy to include patients aged 18 to 21 years with moderate to severe OSA who are unable to use CPAP.
Children with congenital heart disease and comorbid obstructive sleep apnea are at increased risk for impaired neurocognition compared with children with congenital heart disease who do not have comorbid OSA.
The WatchPAT device was able to accurately detect comorbid obstructive sleep apnea in patients with COPD.
Physiologic traits that cause obstructive sleep apnea are also associated with adherence to continuous positive airway pressure in patients with stroke.